HomeNewsBusinessPersonal FinanceHealth-tech firms offering subscription-based, ‘insurance-like’ products on IRDAI’s radar

Health-tech firms offering subscription-based, ‘insurance-like’ products on IRDAI’s radar

Easier capital requirement norms and quicker regulatory approvals for insurers on the cards

April 18, 2022 / 23:34 IST
Story continues below Advertisement
Representative image
Representative image

The Insurance Regulatory and Development Authority of India (IRDAI) is planning a series of measures to ease compliance burden for insurers, ensure faster regulatory approvals and increase insurance penetration in the country. Newly-appointed IRDAI chairman Debashish Panda on April 7 said that the regulator plans to form working groups to recommend easing of various processes and restrictions.

However, health-tech companies that offer individual customers subscription-based plans to meet their out-of-pocket as well as hospitalisation expenses will soon have to explain their actions to IRDAI. “We have come across such companies. We have called for data and have asked them to modify information on their websites. We will shortly come up with an action plan. We are taking this very seriously,” said TL Alamelu, Member (non-life) IRDAI. Such companies offer ‘alternatives’ to health insurance plans, but are not regulated by IRDAI.

Story continues below Advertisement

Also listen: Simply Save: Know the importance of buying an adequate health insurance cover

Easier norms for new entrants in select segments?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show